Investigator Sponsored Trials

Pharmatech Oncology conducts a vigorous program of investigator sponsored clinical trials (IST). We offer opportunities for investigators to develop and conduct multi-center clinical trials through the Network. Successful ISTs produce publications, new compendium treatments, and distinguish trial sponsors as leaders in the oncology community.

We support our investigator sponsors to develop and conduct thoughtful, well designed clinical trials. Research concepts are developed as proposals and presented to the appropriate companies for funding. Our multi-center ISTs are centrally administered with protocol development, regulatory, enrollment, data, and medical writing provided by Pharmatech. Our goal is to deliver clinically meaningful scientific abstracts and publications with the highest quality of patient care.

Contact us to discuss your research concepts and initiate an evaluation of IST funding opportunities in the Pharmatech Oncology Network.